BNP Paribas Financial Markets’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-43
| Closed | -$304 | – | 3348 |
|
|
2023
Q2 | $304 | Hold |
43
| – | – | ﹤0.01% | 3189 |
|
|
2023
Q1 | $319 | Sell |
43
-100
| -70% | -$742 | ﹤0.01% | 3109 |
|
|
2022
Q4 | $1.04K | Sell |
143
-95
| -40% | -$690 | ﹤0.01% | 3133 |
|
|
2022
Q3 | $2.31K | Sell |
238
-1,061
| -82% | -$10.3K | ﹤0.01% | 3616 |
|
|
2022
Q2 | $24.8K | Buy |
1,299
+1,106
| +573% | +$21.1K | ﹤0.01% | 3035 |
|
|
2022
Q1 | $9.61K | Sell |
193
-240
| -55% | -$12K | ﹤0.01% | 3236 |
|
|
2021
Q4 | $32.7K | Buy |
433
+57
| +15% | +$4.3K | ﹤0.01% | 3161 |
|
|
2021
Q3 | $29.7K | Buy |
376
+284
| +309% | +$22.4K | ﹤0.01% | 3008 |
|
|
2021
Q2 | $12.7K | Sell |
92
-78
| -46% | -$10.8K | ﹤0.01% | 3065 |
|
|
2021
Q1 | $35.6K | Sell |
170
-28
| -14% | -$5.87K | ﹤0.01% | 3117 |
|
|
2020
Q4 | $32.8K | Sell |
198
-53
| -21% | -$8.78K | ﹤0.01% | 3068 |
|
|
2020
Q3 | $42.6K | Buy |
251
+211
| +528% | +$35.8K | ﹤0.01% | 2931 |
|
|
2020
Q2 | $6.59K | Sell |
40
-187
| -82% | -$30.8K | ﹤0.01% | 3259 |
|
|
2020
Q1 | $26.3K | Buy |
227
+81
| +55% | +$9.39K | ﹤0.01% | 3215 |
|
|
2019
Q4 | $21.6K | Buy |
146
+84
| +135% | +$12.4K | ﹤0.01% | 3309 |
|
|
2019
Q3 | $8.52K | Buy |
62
+12
| +24% | +$1.65K | ﹤0.01% | 3543 |
|
|
2019
Q2 | $6.45K | Buy |
+50
| New | +$6.45K | ﹤0.01% | 3573 |
|